Private EquityRIA · CRD 282650SEC-Registered

Updated:

MSA Capital

Jenny Zeng’s MSA Capital manages over $2B across biotech and enterprise tech, with a dedicated Middle East and Africa practice run by a former Wamda...

MSA Capital logo

MSA Capital

MSA Capital launched in 2014 with Jenny Zeng, the former first Executive Director of the China Venture Capital and Private Equity Association, at the helm. Zeng brought an unusual blend of policy fluency and early-stage networks, having founded one of the first boutique investment banks in China. That background shaped a firm that runs more like a venture studio than a conventional Asian growth fund. The firm deploys capital across biotechnology, enterprise-facing core technology, and mobility. Its stage coverage spans seed, start-up, expansion, and late-stage growth, with the in-house MSA Spark program incubating companies from concept. Named portfolio companies include Nio, BOSS Zhipin, Mobike, Yidu Cloud, Pyrotech, and Sironax (per firm website). On the biotech side, Partner James Feng — previously Executive Director at YuanBio Venture — leads investments in next-generation therapeutics. Walid, a former Wamda Capital Partner, runs the firm’s Emerging Technology Markets practice out of the Middle East and Africa, a structural rarity among China-headquartered venture managers that gives MSA direct origination capability from Cairo to Riyadh. The firm manages over $2 billion and operates with a lean partnership group spanning Beijing, MEA advisory ties, and operating-company roots. Its principals have driven landmark regional exits including Careem’s sale to Uber and Souq’s sale to Amazon prior to joining MSA. Recent operational signals are thin, though the firm continues to emphasize the MSA Spark incubation engine and has publicly highlighted its 2021 recognitions from Private Equity International for Firm of the Year – China and Exit of the Year – Asia. What sets MSA apart is its deliberate dual-hub architecture: a China deep-tech and biotech core alongside a dedicated MEA emerging-markets practice. Most cross-border venture firms route Middle East capital into Chinese assets; MSA instead places a former regional VC Partner on its leadership team to build and manage a direct portfolio on the ground. That structure makes it an unusual conduit between Chinese innovation and frontier-market digitization.

General information

Firm type

Private Equity

Year founded

2014

AUM

Over $2 billion (per firm website)

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Principals

Jenny Zeng

Founder and Managing Partner

James Feng

Partner

Hanae Kawada

Partner

Jiali Mao

Chief Operating Officer

Walid

Partner, Chief Operating Officer for Emerging Technology Markets

Sector focus

BiotechnologyEnterprise SoftwareAI/MLMobility & TransportationDigital Health

Frequently asked questions

Who runs investment decisions at MSA Capital?

Founder and Managing Partner Jenny Zeng oversees all China investments. The healthcare team is led by Partner James Feng, while Partner Hanae Kawada focuses on enterprise-facing core technology. Walid, a Partner and COO of Emerging Technology Markets, leads the firm’s Middle East and Africa practice. Each partner has autonomous coverage with central coordination from Beijing, per the firm’s website.

How does MSA Capital source deal flow in the Middle East and Africa?

MSA’s MEA practice is led by Walid, a former Partner at Wamda Capital and Investment Manager at MENA Venture Investments. His track record includes originating or managing investments in Careem (acquired by Uber), Souq (acquired by Amazon), and Yemeksepeti (acquired by Delivery Hero). That on-the-ground operator network provides proprietary access to regional entrepreneurs, a sourcing channel most China-headquartered venture firms do not hold directly.

What investment stages does MSA Capital target?

MSA covers the full venture lifecycle: seed, start-up, expansion, and late-stage growth. The firm also operates MSA Spark, a program designed to co-create companies from concept alongside founders, providing venture capital, management support, and human-resources infrastructure. This allows the firm to enter deals at formation and follow on through growth rounds.

Does MSA Capital function like a venture capital fund or something else?

MSA is structured as a global investment firm focused on private venture and growth assets. Its blend of traditional VC investing, in-house company incubation through MSA Spark, and a dedicated emerging-markets practice makes its model closer to a venture platform with operating-company creation capability than a standard limited-partner fund.

Which sectors does MSA Capital focus on?

The firm’s stated focus is biotechnology and enterprise-facing core technology. In practice, its portfolio spans electric vehicles (Nio), AI-driven health data (Yidu Cloud), online recruitment (BOSS Zhipin), mobility (Mobike), and next-generation drug development (Sironax, Pyrotech). These cluster around deep-tech and life sciences positions with global scalability.

Does MSA Capital maintain any philanthropic or impact structures?

MSA is a signatory to the UN Principles for Responsible Investment and was the first Asian-headquartered private-markets firm to adopt the ILPA Diversity, Equity and Inclusion framework. The firm and its principals separately support The Nature Conservancy, the Beijing Apple Charity Foundation (focused on education, medical care, and environmental protection in Tibet), and the Heart of China Foundation.

How is MSA Capital different from other China-headquartered venture firms investing globally?

Most peers either invest capital from the Middle East into Chinese assets or send small deal teams abroad. MSA embedded a senior Middle East partner directly into its leadership team, with a mandate to build and manage a dedicated on-the-ground portfolio. That dual-hub structure — Beijing for China deep-tech and biotech, MEA for emerging-technology markets — gives the firm a genuinely bilateral rather than export-oriented capital flow.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles